Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release.
Thote
Amol J
AJ
Gupta
Ram B
RB
D002245:Carbon Dioxide / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D003907:Dexamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D004339:Drug Compounding / Q000379:methods*; D016503:Drug Delivery Systems / Q000295:instrumentation*; D006801:Humans; D066298:In Vitro Techniques; D008863:Microspheres; D036103:Nanotechnology / Q000379:methods*; D010316:Particle Size
D003692:Delayed-Action Preparations; D002245:Carbon Dioxide; C004180:dexamethasone 21-phosphate; D003907:Dexamethasone